Intarcia Therapeutics logo

Intarcia Therapeutics

Formerly BioMedicines, Intarcia Therapeutics is an American biopharmaceutical company developing therapies for diseases with long-term treatment requirements.

4

Funding Rounds

$479.5m

Money raised

Overview

Formerly BioMedicines, Intarcia Therapeutics is an American biopharmaceutical company developing therapies for diseases with long-term treatment requirements.
Name Email Phone Social networks
Pa***** Co**** - - linkedin facebook
Na*** Th******** - - linkedin
Ku** Gr****
  • ****.******@intarcia.com
- -
Ja* S. Sk**** - - -
Gi** Sa***** - - -

Funding

Funding series

Funding Series Analysis

The company Intarcia Therapeutics has raised a total of $479.49m in funding over 4 rounds.

Key Insights:

  • Intarcia Therapeutics series E funding round: $200m
  • Intarcia Therapeutics , September 2016: $215m
  • Intarcia Therapeutics funding round, May 2010: $14.49m
  • Intarcia Therapeutics Series B round: $50m
Intarcia Therapeutics logo
Intarcia Therapeutics series E funding round $200m
Intarcia Therapeutics logo
Intarcia Therapeutics , September 2016 $215m
Intarcia Therapeutics logo
Intarcia Therapeutics funding round, May 2010 $14.49m
Intarcia Therapeutics logo
Intarcia Therapeutics Series B round $50m

Industries

Intarcia Therapeutics is active in the following industries: